The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Quay Steven C since 2006.
This trader's CIK number is 1008227.
At the time of last reporting, Quay Steven C was the President & CEO of Atossa Therapeutics, Inc.. (stock ticker symbol ATOS).
Also see all insider trading activities at Atossa Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | ATOS | 11,239 | $9,890 | 0 | $0 | 0 | $0 |
2016 | ATOS | 80,000 | $23,500 | 0 | $0 | 0 | $0 |
2013 | ATOS | 0 | $0 | 7,265 | $41,105 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2007 | NSTK | 0 | $0 | 34,630 | $423,662 | 0 | $0 |
2006 | NSTK | 0 | $0 | 27,332 | $434,993 | 2,667 | $26,083 |
1. Atossa Therapeutics, Inc. (ATOS)
2. Nastech Pharmaceutical Co Inc (NSTK)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-05-21 | ATOS | Buy | 11,239 | .88 | 9,890 |
2016-03-09 | ATOS | Buy | 15,000 | .37 | 5,550 |
2016-02-16 | ATOS | Buy | 15,000 | .53 | 7,950 |
2016-01-19 | ATOS | Buy | 50,000 | .20 | 10,000 |
2013-10-01 | ATOS | Sale | 7,265 | 5.66 | 41,105 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2007-09-27 | NSTK | Sale | 5,200 | 13.57 | 70,564 |
2007-07-25 | NSTK | Sale | 5,800 | 12.23 | 70,963 |
2007-06-07 | NSTK | Sale | 6,400 | 11.05 | 70,720 |
2007-04-18 | NSTK | Sale | 5,850 | 12.04 | 70,410 |
2007-02-27 | NSTK | Sale | 6,130 | 11.50 | 70,519 |
2007-01-25 | NSTK | Sale | 5,250 | 13.43 | 70,486 |
2006-11-15 | NSTK | Sale | 3,620 | 19.56 | 70,818 |
2006-10-09 | NSTK | Sale | 5,175 | 15.62 | 80,807 |
2006-08-08 | NSTK | Sale | 5,820 | 13.88 | 80,764 |
2006-04-25 | NSTK | Sale | 5,100 | 15.75 | 80,345 |
2006-04-11 | NSTK | Option Ex | 2,667 | 9.78 | 26,083 |
2006-04-11 | NSTK | Sale | 2,667 | 15.83 | 42,218 |
2006-03-16 | NSTK | Sale | 4,950 | 16.17 | 80,041 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Quay Steven C (President & CEO of Atossa Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.